摘要
目的:评价动脉导管未闭超声下介入封堵治疗先心病的临床疗效与安全性。方法:对我院60例接受介入封堵治疗的PDA患者使用动脉导管未闭超声下介入封堵术治疗。结果:所有患者均一次置放手术成功,封堵术后一般情况恢复良好,心脏超声检查未显示有分流,肺动脉收缩压由100.4±9.5 mmHg降至72.7±8.6mmHg,肺动脉平均压由75.8±8.8mmHg降至45.6±9.7mmHg,差异有统计学意义(P<0.05);7～11 d出院,术后出现喉返神经损伤声音嘶哑1例,气胸3例,肺不张3例;术后随访期限1～3年,均无动静脉血管瘘,封堵器脱落栓塞、移位,机械性溶血,血栓形成和栓塞,感染性心内膜炎等严重并发症并发症。结论:采用动脉导管未闭超声下介入封堵治疗先心病安全有效,封堵成功率高、创伤小、无需输血、术后恢复快、住院时间短、并发症少等有点,但是价格较昂贵,限制了推广应用。
Objective evaluate congenital heart disease Patent ductus arteriosus transcatheter closure under uhrasonography clinical efficacy and safety. Methods 60 receiving transcatheter closure treatment PDA patients were taken transeatheter closure under ultrasonography to treat in our hospital. Results All patients were placed first successful operation, closure generally recovered well after surgery, echoeardiography revealed no shunt, pulmonary artery systolic pressure from the 100.4 ±9.5 mmHg reduced to 72.7 ± 8.6mmHg, mean pulmonary artery pressure from 75.8 ±8.8mmHg reduced to 45.6 ±9.7mmHg, the difference was significant （P〈0.05）; 7 - 11 d discharged , after surgery 1 ease was recurrent laryngeal nerve injury in a hoarse voice, 3 cases was pneumothorax, 3 cases was ateleetasis; postoperative follow-up period of 1 to 3 years, there was no arteriovenous fistula occluder embolization off, shift, mechanical hemolysis, thrombosis and embolism, infective endocarditis and other serious complications, complications.Conclusion use transcatheter closure under ultrasonography to treat congenital heart disease Patent ductus arteriosus efficacy and safety, block success rate high, less trauma, no blood transfusion, rapid postoperative recovery, shorter hospital stay, fewer complications a bit, but more expensive, limiting the application.
出处
《内蒙古中医药》
2011年第5期1-2,共2页
Inner Mongolia Journal of Traditional Chinese Medicine
关键词
动脉导管未闭
超声
介入封堵
先心病
Patent ductus arteriosus
ultrasound
transcatheter closure
congenital heart disease
